Is the Capstan Compass system approved for commercial use in the US?
CINCINNATI (WKRC) – The Christ Hospital Health Network says its team performed the first U.S. procedure using an investigational robotic system for mitral valve replacement.
The procedure took place Nov. 9 as part of a Food and Drug Administration-authorized early feasibility study, according to Capstan Medical, which developed the system. The team was led by Dr. Santiago Garcia, director of The Christ Hospital’s Structural Heart Program.
The Capstan Compass system combines a flexible catheter, robotic navigation and a valve implant. Doctors control the catheter and position the implant with a handheld controller, the companies said…